We have achieved our position as leaders in the pharmaceutical industry thanks to the commitment to contribute to improving the health of the population, as well as the significant effort to diversify our portfolio.
Since 2005, we have been developing and producing high specialty drugs aimed at chronic degenerative diseases, which has allowed us to stand out in therapeutic areas such as Endocrinology and Metabolism, Anti-infectives, Neurology and Immunology.
Learn about the 16 therapeutic areas that currently integrate the Landsteiner Scientific® portfolio